The Biomarker: Melanoma
Sanjiv S. Agarwala, MD
Video Categories: The Biomarker
Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.
Dr Sibylle Loibl explains how fulvestrant (with or without palbociclib) fits in the treatment paradigm for patients with HR+/ HER2-negative metastatic breast cancer.